These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
440 related articles for article (PubMed ID: 34143766)
1. The landscape of antibody binding in SARS-CoV-2 infection. Heffron AS; McIlwain SJ; Amjadi MF; Baker DA; Khullar S; Armbrust T; Halfmann PJ; Kawaoka Y; Sethi AK; Palmenberg AC; Shelef MA; O'Connor DH; Ong IM PLoS Biol; 2021 Jun; 19(6):e3001265. PubMed ID: 34143766 [TBL] [Abstract][Full Text] [Related]
2. The landscape of antibody binding in SARS-CoV-2 infection. Heffron AS; McIlwain SJ; Amjadi MF; Baker DA; Khullar S; Sethi AK; Palmenberg AC; Shelef MA; O'Connor DH; Ong IM bioRxiv; 2021 Jan; ():. PubMed ID: 33052349 [TBL] [Abstract][Full Text] [Related]
3. Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray. Camerini D; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Shandling A; Huynh V; Teng AA; Hermanson G; Pablo JV; Stumpf MM; Lester SN; Harcourt J; Tamin A; Rasheed M; Thornburg NJ; Satheshkumar PS; Liang X; Kennedy RB; Yee A; Townsend M; Campo JJ Microbiol Spectr; 2021 Oct; 9(2):e0141621. PubMed ID: 34704808 [TBL] [Abstract][Full Text] [Related]
4. Peptide microarray-based analysis of antibody responses to SARS-CoV-2 identifies unique epitopes with potential for diagnostic test development. Holenya P; Lange PJ; Reimer U; Woltersdorf W; Panterodt T; Glas M; Wasner M; Eckey M; Drosch M; Hollidt JM; Naumann M; Kern F; Wenschuh H; Lange R; Schnatbaum K; Bier FF Eur J Immunol; 2021 Jul; 51(7):1839-1849. PubMed ID: 33772767 [TBL] [Abstract][Full Text] [Related]
5. Epitope profiling reveals binding signatures of SARS-CoV-2 immune response in natural infection and cross-reactivity with endemic human CoVs. Stoddard CI; Galloway J; Chu HY; Shipley MM; Sung K; Itell HL; Wolf CR; Logue JK; Magedson A; Garrett ME; Crawford KHD; Laserson U; Matsen FA; Overbaugh J Cell Rep; 2021 May; 35(8):109164. PubMed ID: 33991511 [TBL] [Abstract][Full Text] [Related]
6. Dynamic landscape mapping of humoral immunity to SARS-CoV-2 identifies non-structural protein antibodies associated with the survival of critical COVID-19 patients. Cheng L; Zhang X; Chen Y; Wang D; Zhang D; Yan S; Wang H; Xiao M; Liang T; Li H; Xu M; Hou X; Dai J; Wu X; Li M; Lu M; Wu D; Tian R; Zhao J; Zhang Y; Cao W; Wang J; Yan X; Zhou X; Liu Z; Xu Y; He F; Li Y; Yu X; Zhang S Signal Transduct Target Ther; 2021 Aug; 6(1):304. PubMed ID: 34404759 [TBL] [Abstract][Full Text] [Related]
7. Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients. Sasson JM; Campo JJ; Carpenter RM; Young MK; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Teng AA; Pablo JV; Liang X; Yee A; Petri WA; Camerini D mBio; 2021 Jun; 12(3):e0122921. PubMed ID: 34182775 [TBL] [Abstract][Full Text] [Related]
8. Identification of immunodominant epitopes on nucleocapsid and spike proteins of the SARS-CoV-2 in Iranian COVID-19 patients. Maghsood F; Shokri MR; Jeddi-Tehrani M; Torabi Rahvar M; Ghaderi A; Salimi V; Kardar GA; Zarnani AH; Amiri MM; Shokri F Pathog Dis; 2022 Feb; 80(1):. PubMed ID: 34994386 [TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 immune repertoire in MIS-C and pediatric COVID-19. Ravichandran S; Tang J; Grubbs G; Lee Y; Pourhashemi S; Hussaini L; Lapp SA; Jerris RC; Singh V; Chahroudi A; Anderson EJ; Rostad CA; Khurana S Nat Immunol; 2021 Nov; 22(11):1452-1464. PubMed ID: 34611361 [TBL] [Abstract][Full Text] [Related]
10. Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study. Guo L; Wang Y; Kang L; Hu Y; Wang L; Zhong J; Chen H; Ren L; Gu X; Wang G; Wang C; Dong X; Wu C; Han L; Wang Y; Fan G; Zou X; Li H; Xu J; Jin Q; Cao B; Wang J Emerg Microbes Infect; 2021 Dec; 10(1):664-676. PubMed ID: 33734013 [TBL] [Abstract][Full Text] [Related]
11. From Multiplex Serology to Serolomics-A Novel Approach to the Antibody Response against the SARS-CoV-2 Proteome. Butt J; Murugan R; Hippchen T; Olberg S; van Straaten M; Wardemann H; Stebbins E; Kräusslich HG; Bartenschlager R; Brenner H; Laketa V; Schöttker B; Müller B; Merle U; Waterboer T Viruses; 2021 Apr; 13(5):. PubMed ID: 33923338 [TBL] [Abstract][Full Text] [Related]
12. Mining of linear B cell epitopes of SARS-CoV-2 ORF8 protein from COVID-19 patients. Wang X; Lam JY; Chen L; Au SW; To KKW; Yuen KY; Kok KH Emerg Microbes Infect; 2021 Dec; 10(1):1016-1023. PubMed ID: 34003073 [TBL] [Abstract][Full Text] [Related]
13. The immunodominant and neutralization linear epitopes for SARS-CoV-2. Lu S; Xie XX; Zhao L; Wang B; Zhu J; Yang TR; Yang GW; Ji M; Lv CP; Xue J; Dai EH; Fu XM; Liu DQ; Zhang L; Hou SJ; Yu XL; Wang YL; Gao HX; Shi XH; Ke CW; Ke BX; Jiang CG; Liu RT Cell Rep; 2021 Jan; 34(4):108666. PubMed ID: 33503420 [TBL] [Abstract][Full Text] [Related]
15. Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses. Wratil PR; Schmacke NA; Karakoc B; Dulovic A; Junker D; Becker M; Rothbauer U; Osterman A; Spaeth PM; Ruhle A; Gapp M; Schneider S; Muenchhoff M; Hellmuth JC; Scherer C; Mayerle J; Reincke M; Behr J; Kääb S; Zwissler B; von Bergwelt-Baildon M; Eberle J; Kaderali L; Schneiderhan-Marra N; Hornung V; Keppler OT Cell Rep; 2021 Dec; 37(13):110169. PubMed ID: 34932974 [TBL] [Abstract][Full Text] [Related]
16. Antibody Response to SARS-CoV-2 Membrane Protein in Patients of the Acute and Convalescent Phase of COVID-19. Jörrißen P; Schütz P; Weiand M; Vollenberg R; Schrempf IM; Ochs K; Frömmel C; Tepasse PR; Schmidt H; Zibert A Front Immunol; 2021; 12():679841. PubMed ID: 34421894 [TBL] [Abstract][Full Text] [Related]
17. S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit. Nguyen-Contant P; Embong AK; Kanagaiah P; Chaves FA; Yang H; Branche AR; Topham DJ; Sangster MY mBio; 2020 Sep; 11(5):. PubMed ID: 32978311 [TBL] [Abstract][Full Text] [Related]
18. Anti-SARS-CoV-2 Antibodies Within IVIg Preparations: Cross-Reactivities With Seasonal Coronaviruses, Natural Autoimmunity, and Therapeutic Implications. Dalakas MC; Bitzogli K; Alexopoulos H Front Immunol; 2021; 12():627285. PubMed ID: 33679770 [No Abstract] [Full Text] [Related]